R. Blanck

Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)

S. Klineova, R. Farber, A. Harel, 2023, Multiple sclerosis.